Cytokine-mediated regulation of urea transporters during experimental endotoxemia

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 5, 2007, Pages

  Schmidt, Christoph ^a   Höcherl, Klaus ^a   Bucher, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Glucocorticoids; Lipopolysaccharide

Indexed keywords

BETA ACTIN; CARRIER PROTEIN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; UREA TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; GLOMERULUS FILTRATION RATE; HEART RATE; HEMODYNAMIC PARAMETERS; INFLAMMATION; ION TRANSPORT; KIDNEY CONCENTRATING CAPACITY; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE ABSORPTION; MEAN ARTERIAL PRESSURE; METABOLIC REGULATION; MOUSE; NONHUMAN; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UREA BLOOD LEVEL; URINE OSMOLALITY;

EID: 34247624782     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00460.2006     Document Type: Article

References (65)

1. Abraham E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25: 556-566, 1999.
2. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. Cochr Database Syst Rev CD002243, 2004.
3. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871, 2002.
4. Armsen TR, Joppich R, Schubert G, Edel HH. Single nephron study of intrarenal urea handling in experimental pyelonephritis. Res Exp Med (Berl) 165: 141-152, 1975.
5. Bankir L, Trinh-Trang-Tan MM. Urea and the kidney. In: The Kidney (6th ed.), edited by Brenner B and Rector F. Philadelphia, PA: Saunders, 2000, p. 637-679.
6. Beaumont K, Vaughn DA, Casto R, Printz MP, Fanestil DD. Thiazide diuretic receptors in spontaneously hypertensive rats and 2-kidney 1-clip hypertensive rats. Clin Exp Hypertens A 12: 215-226, 1990.
7. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27: 723-732, 1999.
8. Briegel J, Jochum M, Gippner-Steppert C, Thiel M. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 12, Suppl 17: S70-S74, 2001.
9. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24: 192-198, 1996.
10. Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 29: 1750-1755, 2001.
11. Bucher M, Hobbhahn J, Taeger K, Kurtz A. Cytokine-mediated down-regulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282: R979-R984, 2002.
12. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 38: 177-182, 2001.
13. Bucher M, Kees F, Taeger K, Kurtz A. Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 31: 566-571, 2003.
14. Bucher M, Taeger K. Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med 28: 642-647, 2002.
15. Camussi G, Ronco C, Montrucchio G, Piccoli G. Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 66: S38-S42, 1998.
16. Chen HM, Shyr MH, Jan YY, Chen MF. Effects of dopexamine on regional blood flow and leukotriene production in multiple splanchnic sites in endotoxemic rats. Hepato-gastroenterol 53: 39-44, 2006.
17. Chen YC, Cadnapaphornchai MA, Summer SN, Falk S, Li C, Wang W, Schrier RW. Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats. J Am Soc Nephrol 16: 2864-2871, 2005.
18. Chew SL, Lins RL, Daelemans R, De Broe ME. Outcome in acute renal failure. Nephrol Dial Transplant 8: 101-107, 1993.
19. Cole L, Bellomo R, Baldwin I, Hayhoe M, Ronco C. The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Med 29: 1113-1120, 2003.
20. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334: 1697-1702, 1996.
21. Gilbert RM, Weber H, Turchin L, Fine LG, Bourgoignie JJ, Bricker NS. A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis. J Clin Invest 58: 1348-1357, 1976.
22. Grinevich V, Knepper MA, Verbalis J, Reyes I, Aguilera G. Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 65: 54-62, 2004.
23. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 74: 243-248, 1983.
24. Hsiao G, Shen MY, Chang WC, Cheng YW, Pan SL, Kuo YH, Chen TF, Sheu JR. A novel antioxidant, octyl caffeate, suppression of LPS/IFN-gamma- induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem Pharmacol 65: 1383-1392, 2003.
25. Hu MC, Bankir L, Michelet S, Rousselet G, Trinh-Trang-Tan MM. Massive reduction of urea transporters in remnant kidney and brain of uremic rats. Kidney Int 58: 1202-1210, 2000.
26. Jorres A. Acute renal failure. Extracorporeal treatment strategies. Minerva Med 93: 329-324, 2002.
27. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167: 512-520, 2003.
28. Kiku Y, Matsuzawa H, Ohtsuka H, Terasaki N, Fukuda S, Kon-Nai S, Koiwa M, Yokomizo Y, Sato H, Rosol TJ, Okada H, Yoshino TO. Effects of chlorpromazine, pentoxifylline and dexamethasone on mRNA expression of lipopolysaccharide-induced inflammatory cytokines in bovine peripheral blood mononuclear cells. J Vet Med Sci 64: 723-726, 2002.
29. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, Nagy A, Schuetz A, Lamm P, Knoll A, Peter K. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31: 1068-1074, 2003.
30. Klein JD, Gunn RB, Roberts BR, Sands JM. Down-regulation of urea transporters in the renal inner medulla of lithium-fed rats. Kidney Int 61: 995-1002, 2002.
31. Klein JD, Sands JM, Qian L, Wang X, Yang B. Upregulation of urea transporter UT-A2 and water channels AQP2 and AQP3 in mice lacking urea transporter UT-B. J Am Soc Nephrol 15: 1161-1167, 2004.
32. Knepper MA, Danielson RA, Saidel GM, Johnston KH. Effects of dietary protein restriction and glucocorticoid administration on urea excretion in rats. Kidney Int 8: 303-315, 1975.
33. Knepper MA, Rector F. Urinary concentration and dilution. In: The Kidney, edited by Brenner B and Rector F. Philadelphia, PA: Saunders, 1991, p. 445-482.
34. Knepper MA, Roch-Ramel F. Pathways of urea transport in the mammalian kidney. Kidney Int 31: 629-633, 1987.
35. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996.
36. Li C, Klein JD, Wang W, Knepper MA, Nielsen S, Sands JM, Frokiaer J. Altered expression of urea transporters in response to ureteral obstruction. Am J Physiol Renal Physiol 286: F1154-F1162, 2004.
37. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19: 1196-1198, 2005.
38. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 66: S16-S24, 1998.
39. Lugon JR, Boim MA, Ramos OL, Ajzen H, Schor N. Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 36: 570-575, 1989.
40. Millar CG, Thiemermann C. Carboxy-PTIO, a scavenger of nitric oxide, selectively inhibits the increase in medullary perfusion and improves renal function in endotoxemia. Shock 18: 64-68, 2002.
41. Naruse M, Klein JD, Ashkar ZM, Jacobs JD, Sands JM. Glucocorticoids downregulate the vasopressin-regulated urea transporter in rat terminal inner medullary collecting ducts. J Am Soc Nephrol 8: 517-523, 1997.
42. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002.
43. Nielsen S, Terris J, Smith CP, Hediger MA, Ecelbarger CA, Knepper MA. Cellular and subcellular localization of the vasopressin- regulated urea transporter in rat kidney. Proc Natl Acad Sci USA 93: 5495-5500, 1996.
44. Nin N, Penuelas O, de Paula M, Lorente JA, Fernandez-Segoviano P, Esteban A. Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med 34: 1093-1098, 2006.
45. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25: 1115-1124, 1997.
46. Parker SJ, Watkins PE. Experimental models of gram-negative sepsis. Br J Surg 88: 22-30, 2001.
47. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
48. Peng T, Sands JM, Bagnasco SM. Glucocorticoids inhibit transcription and expression of the UT-A urea transporter gene. Am J Physiol Renal Physiol 282: F853-F858, 2002.
49. Promeneur D, Rousselet G, Bankir L, Bailly P, Cartron JP, Ripoche P, Trinh-Trang-Tan MM. Evidence for distinct vascular and tubular urea transporters in the rat kidney. J Am Soc Nephrol 7: 852-860, 1996.
50. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117-123, 1995.
51. Requintina PJ, Oxenkrug GF. Differential effects of lipopolysaccharide on lipid peroxidation in F344N, SHR rats and BALB/c mice, and protection of melatonin and NAS against its toxicity. Ann NY Acad Sci 993: 325-333, 2003.
52. Sands JM. Mammalian urea transporters. Annu Rev Physiol 65: 543-566, 2003.
53. Sands JM. Molecular mechanisms of urea transport. J Membr Biol 191: 149-163, 2003.
54. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004.
55. Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29: 1910-1915, 2001.
56. Terris JM, Knepper MA, Wade JB. UT-A3: localization and characterization of an additional urea transporter isoform in the IMCD. Am J Physiol Renal Physiol 280: F325-F332, 2001.
57. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
58. Timmer RT, Klein JD, Bagnasco SM, Doran JJ, Verlander JW, Gunn RB, Sands JM. Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues. Am J Physiol Cell Physiol 281: C1318-C1325, 2001.
59. Uchida S, Sohara E, Rai T, Ikawa M, Okabe M, Sasaki S. Impaired urea accumulation in the inner medulla of mice lacking the urea transporter UT-A2. Mol Cell Biol 25: 7357-7363, 2005.
60. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA. Diuretics and mortality in acute renal failure. Crit Care Med 32: 1669-1677, 2004.
61. Van Molle W, Hochepied T, Brouckaert P, Libert C. The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis. Infect Immun 68: 5026-5029, 2000.
62. Wade JB, Lee AJ, Liu J, Ecelbarger CA, Mitchell C, Bradford AD, Terris J, Kim GH, Knepper MA. UT-A2: a 55-kDa urea transporter in thin descending limb whose abundance is regulated by vasopressin. Am J Physiol Renal Physiol 278: F52-F62, 2000.
63. Xu Y, Olives B, Bailly P, Fischer E, Ripoche P, Ronco P, Cartron JP, Rondeau E. Endothelial cells of the kidney vasa recta express the urea transporter HUT11. Kidney Int 51: 138-146, 1997.
64. Yang B, Bankir L. Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol 288: F881-F896, 2005.
65. Yip KP, Tse CM, McDonough AA, Marsh DJ. Redistribution of Na+/H+ exchanger isoform NHE3 in proximal tubules induced by acute and chronic hypertension. Am J Physiol Renal Physiol 275: F565-F575, 1998.